タンパク質キナーゼCイソフォームの活性化とエンドセリン-1媒介によるミオサイト収縮性の欠陥は,心筋麻痺の停止と再注射後に発生する
Rupak Mukherjee1, Kimberly A Apple, Christina E Squires
1Division of Cardiothoracic Surgery Research, 770 MUSC Complex, Suite 625, Medical University of South Carolina, Charleston, SC 29425, USA. mukherr@musc.edu
Circulation
|July 6, 2006
まとめ
エンドオセリン-1 (ET-1) は,心筋梗塞 (CA) の後の心筋機能不全に寄与する. 古典的なタンパク質キナーゼC (PKC) のイソフォームを阻害した逆転ET-1は,
科学分野:
- 心臓病学 心臓病学
- 分子生物学は分子生物学である.
- 生理学 生理学とは
背景:
- エンドオセリン-1 (ET-1) の放出と再注入は,心筋梗塞後の停止 (CA) を伴い,心臓の収縮性を損なう可能性があります.
- ET-1受容体の活性化により,タンパク質キナーゼC (PKC) のイソフォームが誘発され,さまざまな細胞反応が生じます.
研究 の 目的:
- CA.中にET-1誘発の肌細胞収縮機能不全に関与する特定のPKCイソフォームを特定する.
主な方法:
- 豚の左心室筋細胞は,ノルモサーミア,CA,またはET-1/CAの条件に従った.
- クラシック (Beta-I,Beta-II,Gamma) と新型 (Epsilon,Eta) PKCイソフォームの抑制が肌細胞短縮 (PERSHORT) とリラクゼーション (T50) に与える影響を評価した.
主要な成果:
- CAはPERSHORTを減少させ,T50を延長した;ET-1はこれらの効果を悪化させた.
- PKC-Beta-IIまたはPKC-Gammaの抑制は,ET-1/CAおよびCA群でPERSHORTを改善しました.
- 古典的なPKCイソフォームの抑制は,ET-1/CA群でT50を短縮した.
結論:
- クラシックPKCイソフォームを標的にすることは,CA後の心機能に対するET-1の悪影響を軽減します.
- これらの発見は,CAと再注射後の筋細胞機能障害の管理のためにET-1シグナル伝達を抑制する戦略を開発することを支持しています.
関連する概念動画
Amplifying Signals via Enzymatic Cascade
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Calmodulin-dependent Signaling
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:


